Late additionCarve-out
LEO III Fund acquires JPT Peptide Technologies
Deal-Radar editorial team · responsible: Nick Herbig
late addition, source dated 27 Aug 2026: dubag.eu
SourcingClub was not involved in this transaction.
How the deal fits together.
- BioNTech Diagnostics GmbHSeller
- JPT Peptide TechnologiesTarget
- LEO III FundBuyer
Investor: DUBAG Group
Who was involved.
- Buyer
- LEO III Fund
- Target
- JPT Peptide Technologies, Berlin
- Seller
- BioNTech Diagnostics GmbH
- Investor
- DUBAG Group
- Type
- Carve-out
- Country
Germany- Source dated
- 27/08/2026
- Buy-side
- Noerr, (Recht)Valantic (IT)according to the source
- Source
- dubag.eu
Deal-Radar no. 46-183 · added in Week 46/2026, first reported on 27/08/2026 · publicly reported, no guarantee · SourcingClub was not involved in this transaction. Report an error · Sources and limits
We report publicly announced information and link the source; we accept no liability for its accuracy. No offer and no investment, legal or tax advice. The operators of linked pages are responsible for their content. We correct errors as soon as we learn of them.
August 2026 on the Deal-Radar.
3 of 17 deals were of the type Carve-out.
New deals every day. By email on Mondays.
All deals of the previous week in one email, with source and adviser.
Information from public sources, without guarantee and without claim to completeness. No investment or legal advice. Published on 14 November 2026.